{
  "abstract": "Given high rates of antimicrobial resistance,1 British, American and European IUSTI guidelines recommend that management of Mycoplasma genitalium (M. gen) be guided by testing for macrolide resistance.2–4 Guidelines also recommend against screening asymptomatic individuals.",
  "authors": [
    {
      "affiliations": [
        "Department of Infectious Diseases, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy",
        "Department of Diagnostics and Public Health, University of Verona, Verona, Italy"
      ],
      "name": "Roberto Rossotti"
    },
    {
      "affiliations": [
        "Clinical Microbiology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy"
      ],
      "name": "Alice Nava"
    },
    {
      "affiliations": [
        "Department of Diagnostics and Public Health, University of Verona, Verona, Italy"
      ],
      "name": "Evelina Tacconelli"
    },
    {
      "affiliations": [
        "Department of Infectious Diseases, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy",
        "Università degli Studi di Milano-Bicocca, Milan, Italy"
      ],
      "name": "Massimo Puoti"
    }
  ],
  "title": "Correspondence: the recommended resistance-guided treatment of Mycoplasma genitalium infection in symptomatic individuals is not feasible in many Italian settings",
  "uid": "647ff3b4-ab11-558c-aded-941c0e210d5a"
}